← Back to Search

Influenza Vaccine for Flu

Phase 1 & 2
Waitlist Available
Led By Joseph Leventhal, MD, PhD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial will see if transplant patients who stop immunosuppression have similar responses to the flu vaccine compared to healthy people.

Eligible Conditions
  • Influenza

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Analysis of Immune Response in Transplant Recipient Blood Assays

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Transplant recipients (IS)Experimental Treatment1 Intervention
Adults who have received a kidney/stem cell transplant and are currently maintained on standard immunosuppressive therapy will receive the IIV4 (influenza vaccine).
Group II: Transplant recipients (Chimeric)Experimental Treatment1 Intervention
Adults who have received a kidney/stem cell transplant and have achieved chimerism will receive the IIV4 (influenza vaccine).
Group III: ControlsActive Control1 Intervention
Healthy adults who meet inclusion and exclusion criteria will receive the IIV4 (influenza vaccine).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Influenza A virus A/Uruguay/716/2007(H3N2) hemagglutinin antigen (formaldehyde inactivated)
FDA approved

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,585 Previous Clinical Trials
916,918 Total Patients Enrolled
Joseph Leventhal, MD, PhDPrincipal InvestigatorNorthwestern University
1 Previous Clinical Trials
37 Total Patients Enrolled

Media Library

Transplant recipients (Chimeric) Clinical Trial Eligibility Overview. Trial Name: NCT02623075 — Phase 1 & 2
Influenza Research Study Groups: Transplant recipients (Chimeric), Transplant recipients (IS), Controls
Influenza Clinical Trial 2023: Transplant recipients (Chimeric) Highlights & Side Effects. Trial Name: NCT02623075 — Phase 1 & 2
Transplant recipients (Chimeric) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02623075 — Phase 1 & 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does my profile meet the prerequisites for participation in this experiment?

"To qualify for this research, volunteers should be diagnosed with the flu and between 18 to 89 years old. The trial is currently seeking 45 participants."

Answered by AI

What information has been gathered from research conducted with Chimeric transplant recipients?

"At present, there exist 4 live clinical trials assessing transplanted (chimeric) recipients. Out of these studies, one is in Phase 3 and the majority are being conducted out of Columbus, Ohio; though all four locations remain active."

Answered by AI

Are new participants able to join this clinical research project?

"Per clinicaltrials.gov, this investigation is not admitting participants presently, as the posting was last revised on May 22nd 2020 after originally being posted on October 1st 2015. Despite its inactivity, there are 135 other studies that currently require volunteers."

Answered by AI

Does the current trial accommodate individuals who have not yet reached their sixtieth birthday?

"This trial necessitates that potential participants are between 18 and 89 years of age. Meanwhile, 42 studies have been designed for minors while 86 trials cater to seniors."

Answered by AI

What is the current cap on enrollment for this experimental protocol?

"Sadly, recruitment for this clinical trial is no longer active - it was first posted in October 2015 and updated on the 22nd of May 2020. If you are interested in looking into other studies, there are presently 131 trials searching for participants with influenza and 4 trials specifically targeting transplant recipients (Chimeric) that require volunteers."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Influenza Vaccine Responses as a Means of Assessing Immune Competence in Chimeric Kidney/Stem Cell Transplant Recipients
Joseph Leventhal 2015. "Influenza Vaccine Responses as a Means of Assessing Immune Competence in Chimeric Kidney/Stem Cell Transplant Recipients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02623075.
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top